Section 278 of the Bharatiya Nyaya Sanhita (BNS), 2023

 Section 278 of the Bharatiya Nyāya Saṃhitā (BNS), 2023, situated in Chapter XV – Offences affecting Public Health, Safety, Convenience, Decency, and Morals:

💊 Section 278 – Sale of a Drug as a Different Drug or Preparation

📜 Legal Text (Summarized):

Whoever knowingly sells, offers or exposes for sale, or issues from a dispensary a drug or medical preparation as a different drug or preparation, shall be punished with imprisonment (simple or rigorous) for up to six months, or a fine up to ₹5,000, or both. (myjudix.com)

🔍 Key Aspects

Actus Reus: Misrepresenting a drug or medical preparation as something it is not—whether in sale, offer, or dispensation.

Mens Rea: The seller must act knowingly, i.e., with awareness of the misrepresentation.

Penalty: Maximum 6 months’ imprisonment, and/or a fine up to ₹5,000.

🧭 Comparison with IPC

This mirrors IPC Section 276, which also penalizes selling a drug as another drug. The BNS increases the maximum fine from ₹1,000 to ₹5,000, maintaining the same imprisonment cap

📚 Purpose & Practical Implications

Consumer safety & trust: Ensures that individuals receive medications that are accurately described, preventing harm from wrongful drug substitution.

Enforcement scope: Affects pharmacies, dispensaries, hospitals, and distributors—any sale or distribution transaction where a drug is passed off incorrectly.

Public health impact: Critical in safeguarding against medical fraud and protecting patients from unintended medication effects.

✅ Summary Table

ElementDetail
OffenceSelling or dispensing drug under false identity
Intent RequiredMust be knowing misrepresentation
Maximum Penalty≤6 months’ jail, ≤₹5,000 fine, or both
Fines ComparisonEnhanced from IPC’s ₹1,000 limit

 

 

LEAVE A COMMENT

0 comments